Skip to main content

Karyopharm Therapeutics Inc.

KPTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001503802

In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 2 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $206.8M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Karyopharm Therapeutics Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+2 vs. Q2 2025
Shares held
2.98M
−1.44M (−32.6%) vs. Q2 2025
Total value
$19.5M
+$444.0K (+2.3%) vs. Q2 2025
New holders
7
7 more added
Sold out
5
20 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KPTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 52 institutions
Q1 2021: 171 institutionsQ2 2021: 154 institutionsQ3 2021: 134 institutionsQ4 2021: 143 institutionsQ1 2022: 139 institutionsQ2 2022: 150 institutionsQ3 2022: 147 institutionsQ4 2022: 155 institutionsQ1 2023: 132 institutionsQ2 2023: 138 institutionsQ3 2023: 120 institutionsQ4 2023: 120 institutionsQ1 2024: 114 institutionsQ2 2024: 114 institutionsQ3 2024: 91 institutionsQ4 2024: 87 institutionsQ1 2025: 50 institutionsQ2 2025: 50 institutionsQ3 2025: 52 institutionsQ4 2025: 68 institutionsQ1 2026: 77 institutionsQ2 2026: 96 institutions
Value heldQ3 2025: $19.5M
Q1 2021: $637.1MQ2 2021: $608.7MQ3 2021: $334.4MQ4 2021: $347.5MQ1 2022: $501.8MQ2 2022: $302.8MQ3 2022: $364.1MQ4 2022: $334.4MQ1 2023: $340.1MQ2 2023: $145.0MQ3 2023: $102.8MQ4 2023: $63.5MQ1 2024: $113.0MQ2 2024: $58.6MQ3 2024: $49.2MQ4 2024: $41.2MQ1 2025: $13.7MQ2 2025: $19.0MQ3 2025: $19.5MQ4 2025: $69.6MQ1 2026: $98.4MQ2 2026: $206.8M
Institutions holding KPTI and their total value by quarter
QuarterHoldersValue
Q2 202696$206.8M
Q1 202677$98.4M
Q4 202568$69.6M
Q3 202552$19.5M
Q2 202550$19.0M
Q1 202550$13.7M
Q4 202487$41.2M
Q3 202491$49.2M
Q2 2024114$58.6M
Q1 2024114$113.0M
Q4 2023120$63.5M
Q3 2023120$102.8M
Q2 2023138$145.0M
Q1 2023132$340.1M
Q4 2022155$334.4M
Q3 2022147$364.1M
Q2 2022150$302.8M
Q1 2022139$501.8M
Q4 2021143$347.5M
Q3 2021134$334.4M
Q2 2021154$608.7M
Q1 2021171$637.1M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Karyopharm Therapeutics Inc.; share changes are against Q2 2025.

Institutions holding KPTI in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
T. Rowe Price Investment Management, Inc.700,992$4.58M0.00%−27,774−3.8%Reduced
Adage Capital Partners GP, L.L.C.421,322$2.76M0.00%00.0%Unchanged
Vanguard Group Inc408,222$2.67M0.00%−110,047−21.2%Reduced
BlackRock, Inc.231,951$1.52M0.00%−4,690−2.0%Reduced
Catalio Capital Management, LP142,984$935.1K0.17%−3,029−2.1%Reduced
Avidity Partners Management LP134,566$880.1K0.20%00.0%Unchanged
Marshall Wace, LLP128,451$840.1K0.00%00.0%Unchanged
C WorldWide Group Holding A/S100,000$654.0K0.01%00.0%Unchanged
Geode Capital Management, LLC93,289$610.3K0.00%+1,448+1.6%Added
Group One Trading, L.P.68,436$447.6K0.01%−29,464−30.1%Reduced
Renaissance Technologies LLC64,714$423.2K0.00%−1,100−1.7%Reduced
UBS Group AG59,685$390.3K0.00%−102,215−63.1%Reduced
State Street Corp46,342$303.1K0.00%+13,047+39.2%Added
Silverback Asset Management LLC40,000$261.6K0.03%−30,000−42.9%Reduced
Susquehanna International Group, LLP35,339$231.1K0.00%+35,339New
Bridgeway Capital Management, LLC34,873$228.1K0.00%−2,963−7.8%Reduced
Birchview Capital, LP27,985$183.0K0.14%00.0%Unchanged
Ikarian Capital, LLC27,257$178.3K0.04%00.0%Unchanged
Baird Financial Group, Inc.25,932$169.6K0.00%+15,400+146.2%Added
Morgan Stanley25,766$168.5K0.00%+675+2.7%Added
ADAR1 Capital Management, LLC25,000$163.5K0.02%+25,000New
Goldman Sachs Group Inc24,885$162.7K0.00%−84,519−77.3%Reduced
Northern Trust Corp18,876$123.4K0.00%−34−0.2%Reduced
Belvedere Trading LLC14,563$95.2K0.01%+14,563New
XTX Topco Ltd14,402$94.2K0.00%+1,346+10.3%Added
Gsa Capital Partners LLP14,076$92.0K0.01%+182+1.3%Added
Bank of New York Mellon Corp11,086$72.5K0.00%00.0%Unchanged
Price T Rowe Associates Inc10,886$72.0K0.00%00.0%Unchanged
Royal Bank of Canada6,734$44.0K0.00%−695−9.4%Reduced
Simplex Trading, LLC5,862$38.0K0.00%−2,371−28.8%Reduced
Barclays PLC4,109$26.9K0.00%−1,224−23.0%Reduced
TD Waterhouse Canada Inc.3,203$19.9K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,089$7.12K0.00%+239+28.1%Added
FMR LLC679$4.44K0.00%−86−11.2%Reduced
JPMorgan Chase & Co550$3.60K0.00%−255,893−99.8%Reduced
Citigroup Inc513$3.35K0.00%−6,527−92.7%Reduced
Advisor Group Holdings, Inc.346$2.41K0.00%00.0%Unchanged
Quent Capital, LLC231$1.51K0.00%+231New
Rise Advisors, LLC131$8570.00%+131New
MB, Levis & Associates, LLC100$6540.00%00.0%Unchanged
Bank of America Corp94$6150.00%−168,440−99.9%Reduced
Harbour Investments, Inc.85$5560.00%00.0%Unchanged
BNP Paribas Arbitrage, SA82$5360.00%−29,555−99.7%Reduced
Fortitude Family Office, LLC81$5300.00%00.0%Unchanged
SBI Securities Co., Ltd.74$4840.00%00.0%Unchanged
Activest Wealth Management66$4320.00%00.0%Unchanged
Allworth Financial LP26$1710.00%−6−18.8%Reduced
Bruce G. Allen Investments, LLC22$1440.00%00.0%Unchanged
Advisory Services Network, LLC12$780.00%+12New
CIBC Private Wealth Group, LLC3$200.00%00.0%Unchanged
West Branch Capital LLC3$200.00%00.0%Unchanged
Pittenger & Anderson Inc3$200.00%+3New
Eversept Partners, LP0$00.00%−257,154−100.0%Sold out
Citadel Advisors LLC0$00.00%−206,781−100.0%Sold out
Palo Alto Investors LP0$00.00%−187,911−100.0%Sold out
Millennium Management LLC0$00.00%−31,847−100.0%Sold out
Raymond James Financial Inc0$00.00%−90−100.0%Sold out